Bioavailability of drugs to the brain and the blood-brain barrier:
Saved in:
| Format: | Book |
|---|---|
| Language: | Undetermined |
| Published: |
Washington, DC
U.S. Gov. Print. Off.
1992
|
| Series: | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series
120 |
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | IV, 265 S. Ill., graph. Darst. |
| ISBN: | 0160379148 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV006431007 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 930309s1992 ad|| |||| 00||| undod | ||
| 020 | |a 0160379148 |9 0-16-037914-8 | ||
| 035 | |a (OCoLC)243735614 | ||
| 035 | |a (DE-599)BVBBV006431007 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a Bioavailability of drugs to the brain and the blood-brain barrier |c ed.: Jerry Frankenheim ... |
| 264 | 1 | |a Washington, DC |b U.S. Gov. Print. Off. |c 1992 | |
| 300 | |a IV, 265 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |v 120 | |
| 650 | 0 | 7 | |a Halluzinogen |0 (DE-588)4134941-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Stofftransport |g Biologie |0 (DE-588)4443397-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Bioverfügbarkeit |0 (DE-588)4145660-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Blut-Hirn-Schranke |0 (DE-588)4007279-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zentralnervensystem |0 (DE-588)4067637-7 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Halluzinogen |0 (DE-588)4134941-6 |D s |
| 689 | 0 | 1 | |a Zentralnervensystem |0 (DE-588)4067637-7 |D s |
| 689 | 0 | 2 | |a Bioverfügbarkeit |0 (DE-588)4145660-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Halluzinogen |0 (DE-588)4134941-6 |D s |
| 689 | 1 | 1 | |a Blut-Hirn-Schranke |0 (DE-588)4007279-4 |D s |
| 689 | 1 | 2 | |a Stofftransport |g Biologie |0 (DE-588)4443397-9 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Frankenheim, Jerry |e Sonstige |4 oth | |
| 830 | 0 | |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |v 120 |w (DE-604)BV001902214 |9 120 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=004075725&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-004075725 | ||
Record in the Search Index
| _version_ | 1804120682039083008 |
|---|---|
| adam_text | BIOAVAILABILITY OF DRUGS TO THE BRAIN AND THE BLOOD-BRAIN BARRIER
EDITORS: JERRY FRANKENHEIM, PH.D. ROGER M. BROWN, PH.D. RESEARCH
MONOGRAPH 120 1992 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC
HEALTH SERVICE ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE ON DRUG ABUSE 5600 FISHERS LANE ROCKVILLE, MD 20857
CONTENTS PAGE INTRODUCTION 1 JERRY FRANKENHEIM THE BASIC NEUROBIOLOGY OF
ADDICTION 4 ROGER M. BROWN SOME RELATIONSHIPS BETWEEN ADDICTION AND DRUG
DELIVERY TO THE BRAIN 13 WILLIAM H. OLDENDORF NEUROACTIVE PEPTIDES AND
AMINO ACIDS AT THE BLOOD-BRAIN BARRIER: POSSIBLE IMPLICATIONS FOR DRUG
ABUSE 26 BERISLAV V. ZLOKOVIC, J. GORDON MCCOMB, LYNN PERLMUTTER, MARTIN
H. WEISS, AND HUGH DAVSON MPTP TOXICITY AND THE BIOCHEMICAL
BLOOD-BRAIN BARRIER 43 SAMI I. HARIK AN OVERVIEW OF THE MULTIPLE
FUNCTIONS OF THE BLOOD-BRAIN BARRIER 54 A. LORRIS BETZ FORMATION AND
DIFFERENTIATION OF BRAIN CAPILLARIES 73 JOHN LATERRA, JOHANNES E.A.
WOLFF, CHRISTOPHER GUERIN, AND GARY W. GOLDSTEIN NONPERMEABLE AND
PERMEABLE VESSELS OF THE BRAIN 87 MILTON W. BRIGHTMAN AND YOSHIAKI
KADOTA THE BLOOD-BRAIN BARRIER IS NOT A BARRIER FOR MANY DRUGS 108
JOSEPH D. FENSTERMACHER DRUG DELIVERY TO THE BRAIN: BARRIER MODIFICATION
AND DRUG MODIFICATION METHODOLOGIES 121 STANLEY I. RAPOPORT CULTURED
BRAIN MICROVESSEL ENDOTHELIAL CELLS AS IN VITRO MODELS OF THE
BLOOD-BRAIN BARRIER 138 YOSHINOBU TAKAKURA, KENNETH L. AUDUS, AND RONALD
T. BORCHARDT OPIOID PEPTIDE DRUG DEVELOPMENT: TRANSPORT OF OPIOID
CHIMERIC PEPTIDES THROUGH THE BLOOD-BRAIN BARRIER 153 WILLIAM M.
PARDRIDGE REDOX APPROACHES TO DRUG DELIVERY TO THE CENTRAL NERVOUS
SYSTEM 169 MARCUS E. BREWSTER AND NICHOLAS BODOR DRUG DELIVERY TO THE
BRAIN USING AN ANTI-TRANSFERRIN RECEPTOR ANTIBODY 202 PHILLIP M. FRIDEN,
LEE WALUS, MARJORIE TAYLOR, GARY F. MUSSO, SUSAN A. ABELLEIRA, BERNARD
MALFROY, FARIBA TEHRAN!, JOSEPH B. ECKMAN III, ANNE R. MORROW, AND RUTH
M. STARZYK PERMEATION OF THE BLOOD-BRAIN BARRIER FOR DRUG DELIVERY TO
THE BRAIN 218 HEIDI C. HOMER, KARI BARBU, FREDERIQUE BARD, DEBORAH HALL,
MARY JANATPOUR, KATY MANNING, JANINE MORALES, SETH PORTER, PAULETTE E.
SETLER, LAURA TANNER, AND LEE R. RUBIN PATHWAYS INTO, THROUGH, AND
AROUND THE FLUID-BRAIN BARRIERS 230 RICHARD D. BROADWELL LIST OF NIDA
RESEARCH MONOGRAPHS 259 IV
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV006431007 |
| ctrlnum | (OCoLC)243735614 (DE-599)BVBBV006431007 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01973nam a2200445 cb4500</leader><controlfield tag="001">BV006431007</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930309s1992 ad|| |||| 00||| undod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0160379148</subfield><subfield code="9">0-16-037914-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)243735614</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV006431007</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bioavailability of drugs to the brain and the blood-brain barrier</subfield><subfield code="c">ed.: Jerry Frankenheim ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">U.S. Gov. Print. Off.</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IV, 265 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series</subfield><subfield code="v">120</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Stofftransport</subfield><subfield code="g">Biologie</subfield><subfield code="0">(DE-588)4443397-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bioverfügbarkeit</subfield><subfield code="0">(DE-588)4145660-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Blut-Hirn-Schranke</subfield><subfield code="0">(DE-588)4007279-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zentralnervensystem</subfield><subfield code="0">(DE-588)4067637-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Zentralnervensystem</subfield><subfield code="0">(DE-588)4067637-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Bioverfügbarkeit</subfield><subfield code="0">(DE-588)4145660-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Blut-Hirn-Schranke</subfield><subfield code="0">(DE-588)4007279-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Stofftransport</subfield><subfield code="g">Biologie</subfield><subfield code="0">(DE-588)4443397-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Frankenheim, Jerry</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series</subfield><subfield code="v">120</subfield><subfield code="w">(DE-604)BV001902214</subfield><subfield code="9">120</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=004075725&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-004075725</subfield></datafield></record></collection> |
| id | DE-604.BV006431007 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:45:58Z |
| institution | BVB |
| isbn | 0160379148 |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-004075725 |
| oclc_num | 243735614 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | IV, 265 S. Ill., graph. Darst. |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | U.S. Gov. Print. Off. |
| record_format | marc |
| series | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |
| series2 | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |
| spelling | Bioavailability of drugs to the brain and the blood-brain barrier ed.: Jerry Frankenheim ... Washington, DC U.S. Gov. Print. Off. 1992 IV, 265 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series 120 Halluzinogen (DE-588)4134941-6 gnd rswk-swf Stofftransport Biologie (DE-588)4443397-9 gnd rswk-swf Bioverfügbarkeit (DE-588)4145660-9 gnd rswk-swf Blut-Hirn-Schranke (DE-588)4007279-4 gnd rswk-swf Zentralnervensystem (DE-588)4067637-7 gnd rswk-swf Halluzinogen (DE-588)4134941-6 s Zentralnervensystem (DE-588)4067637-7 s Bioverfügbarkeit (DE-588)4145660-9 s DE-604 Blut-Hirn-Schranke (DE-588)4007279-4 s Stofftransport Biologie (DE-588)4443397-9 s Frankenheim, Jerry Sonstige oth National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series 120 (DE-604)BV001902214 120 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=004075725&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Bioavailability of drugs to the brain and the blood-brain barrier National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series Halluzinogen (DE-588)4134941-6 gnd Stofftransport Biologie (DE-588)4443397-9 gnd Bioverfügbarkeit (DE-588)4145660-9 gnd Blut-Hirn-Schranke (DE-588)4007279-4 gnd Zentralnervensystem (DE-588)4067637-7 gnd |
| subject_GND | (DE-588)4134941-6 (DE-588)4443397-9 (DE-588)4145660-9 (DE-588)4007279-4 (DE-588)4067637-7 |
| title | Bioavailability of drugs to the brain and the blood-brain barrier |
| title_auth | Bioavailability of drugs to the brain and the blood-brain barrier |
| title_exact_search | Bioavailability of drugs to the brain and the blood-brain barrier |
| title_full | Bioavailability of drugs to the brain and the blood-brain barrier ed.: Jerry Frankenheim ... |
| title_fullStr | Bioavailability of drugs to the brain and the blood-brain barrier ed.: Jerry Frankenheim ... |
| title_full_unstemmed | Bioavailability of drugs to the brain and the blood-brain barrier ed.: Jerry Frankenheim ... |
| title_short | Bioavailability of drugs to the brain and the blood-brain barrier |
| title_sort | bioavailability of drugs to the brain and the blood brain barrier |
| topic | Halluzinogen (DE-588)4134941-6 gnd Stofftransport Biologie (DE-588)4443397-9 gnd Bioverfügbarkeit (DE-588)4145660-9 gnd Blut-Hirn-Schranke (DE-588)4007279-4 gnd Zentralnervensystem (DE-588)4067637-7 gnd |
| topic_facet | Halluzinogen Stofftransport Biologie Bioverfügbarkeit Blut-Hirn-Schranke Zentralnervensystem |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=004075725&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV001902214 |
| work_keys_str_mv | AT frankenheimjerry bioavailabilityofdrugstothebrainandthebloodbrainbarrier |